An mRNA influenza vaccine bests an inactivated quadrivalent flu vaccine against two different strains in phase 3 study.

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

For decades, the flu virus in the shots you’re offered every fall has been grown in chicken eggs. Now, scientists are trying ...

As vaccine policy uncertainty reaches a new level in the U.S., the Centers for Disease Control and Prevention's (CDC’s) team ...

The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...

Pregnant people have a higher risk of severe disease and death from COVID, so making it harder for them to get vaccinated ...

A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process.

In a time when misinformation and political theater often drown out facts, President Trump’s message matters more than ever.

The FDA’s top vaccine regulator asserted in a staff email that the Covid vaccine caused at least 10 kids' deaths, but experts ...